PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-76

  1. 9,806 Posts.
    lightbulb Created with Sketch. 1243
    yep I'd wait of FDA direction also given serial past misses in OA space
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.